» Articles » PMID: 26359402

Six Enzymes from Mayapple That Complete the Biosynthetic Pathway to the Etoposide Aglycone

Overview
Journal Science
Specialty Science
Date 2015 Sep 12
PMID 26359402
Citations 154
Authors
Affiliations
Soon will be listed here.
Abstract

Podophyllotoxin is the natural product precursor of the chemotherapeutic etoposide, yet only part of its biosynthetic pathway is known. We used transcriptome mining in Podophyllum hexandrum (mayapple) to identify biosynthetic genes in the podophyllotoxin pathway. We selected 29 candidate genes to combinatorially express in Nicotiana benthamiana (tobacco) and identified six pathway enzymes, including an oxoglutarate-dependent dioxygenase that closes the core cyclohexane ring of the aryltetralin scaffold. By coexpressing 10 genes in tobacco-these 6 plus 4 previously discovered-we reconstitute the pathway to (-)-4'-desmethylepipodophyllotoxin (the etoposide aglycone), a naturally occurring lignan that is the immediate precursor of etoposide and, unlike podophyllotoxin, a potent topoisomerase inhibitor. Our results enable production of the etoposide aglycone in tobacco and circumvent the need for cultivation of mayapple and semisynthetic epimerization and demethylation of podophyllotoxin.

Citing Articles

Plant metabolomics: applications and challenges in the era of multi-omics big data.

Hao Y, Zhang Z, Luo E, Yang J, Wang S aBIOTECH. 2025; 6(1):116-132.

PMID: 40060186 PMC: 11889285. DOI: 10.1007/s42994-024-00194-0.


A long road ahead to reliable and complete medicinal plant genomes.

Cheng L, Wang Z, Zhu Q, Ye M, Ye C Nat Commun. 2025; 16(1):2150.

PMID: 40032878 PMC: 11876585. DOI: 10.1038/s41467-025-57448-8.


Cloning and bioinformatics analysis of key gene ShOMT3 of podophyllotoxin biosynthesis pathway in Sinopodophyllum hexandrum.

Liu W, Gao H, Zhao D, Li S, Li L, Zhao X PLoS One. 2025; 20(2):e0314919.

PMID: 39951440 PMC: 11828346. DOI: 10.1371/journal.pone.0314919.


Advances in the biosynthesis of naturally occurring benzylisoquinoline alkaloids.

Zhao W, Liu J, Chen Y Front Plant Sci. 2025; 16:1548471.

PMID: 39949415 PMC: 11821938. DOI: 10.3389/fpls.2025.1548471.


When synthetic biology meets medicine.

Feng Y, Su C, Mao G, Sun B, Cai Y, Dai J Life Med. 2025; 3(1):lnae010.

PMID: 39872399 PMC: 11749639. DOI: 10.1093/lifemedi/lnae010.


References
1.
Marques J, Kim K, Lee C, Costa M, May G, Crow J . Next generation sequencing in predicting gene function in podophyllotoxin biosynthesis. J Biol Chem. 2012; 288(1):466-79. PMC: 3537044. DOI: 10.1074/jbc.M112.400689. View

2.
Kamal A, Hussaini S, Rahim A, Riyaz S . Podophyllotoxin derivatives: a patent review (2012 - 2014). Expert Opin Ther Pat. 2015; 25(9):1025-34. DOI: 10.1517/13543776.2015.1051727. View

3.
Davin L, Wang H, Crowell A, Bedgar D, Martin D, Sarkanen S . Stereoselective bimolecular phenoxy radical coupling by an auxiliary (dirigent) protein without an active center. Science. 1997; 275(5298):362-6. DOI: 10.1126/science.275.5298.362. View

4.
Cimermancic P, Medema M, Claesen J, Kurita K, Wieland Brown L, Mavrommatis K . Insights into secondary metabolism from a global analysis of prokaryotic biosynthetic gene clusters. Cell. 2014; 158(2):412-421. PMC: 4123684. DOI: 10.1016/j.cell.2014.06.034. View

5.
Thodey K, Galanie S, Smolke C . A microbial biomanufacturing platform for natural and semisynthetic opioids. Nat Chem Biol. 2014; 10(10):837-44. PMC: 4167936. DOI: 10.1038/nchembio.1613. View